New Survey Documents Extent of Lab Business Damage Inflicted by COVID-19

The fact that the lab business is taking a beating as a result of the COVID-19 pandemic is hardly news. But a recent survey sheds important new light on the extent of the devastation. The Kalorama Survey Healthcare market data and consulting firm Kalorama Information conducted the survey of 191 clinical labs across the U.S. (most of them hospital-based), excluding New York City, New Orleans and other pandemic hot spots to avoid skewing the results. The survey, which was conducted in the third week of April, shows a massive reduction in testing volume due to the pandemic. Overall, 59% of labs surveyed reported COVID-19 as having a significant impact on lab operations with larger labs more likely to report significant impact than smaller labs. Source: Kalorama Information